{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:04:20Z","timestamp":1790913860156,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3096,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.virol.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,2,2]],"date-time":"2005-02-02T08:46:55Z","timestamp":1107334015000},"page":"201-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Pim kinases are upregulated during Epstein\u2013Barr virus infection and enhance EBNA2 activity"],"prefix":"10.1016","volume":"333","author":[{"given":"Eeva-Marja","family":"Rainio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Ahlfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Ruuska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampsa","family":"Matikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Kieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi J.","family":"Koskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2005.01.001_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0042-6822(91)90893-G","article-title":"Early events in Epstein\u2013Barr virus infection of human B lymphocytes","volume":"181","author":"Alfieri","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.01.001_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.febslet.2004.06.050","article-title":"Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site","volume":"571","author":"Aho","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virol.2005.01.001_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.onc.1201288","article-title":"Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc","volume":"15","author":"Allen","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.virol.2005.01.001_bib4","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1073\/pnas.86.22.8857","article-title":"The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias","volume":"86","author":"Amson","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2005.01.001_bib5","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1038\/sj.onc.1203217","article-title":"Epstein\u2013Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-\u03baB","volume":"18","author":"Cahir-McFarland","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.virol.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/bj3210125","article-title":"The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development","volume":"321","author":"Callebaut","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.virol.2005.01.001_bib7","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1128\/JVI.76.20.10427-10436.2002","article-title":"Epstein\u2013Barr virus-induced changes in B-lymphocyte gene expression","volume":"76","author":"Carter","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.001_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature01956","article-title":"A micrococcal nuclease homologue in RNAi effector complexes","volume":"425","author":"Caudy","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2005.01.001_bib9","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1073\/pnas.042035699","article-title":"Pim serine\/threonine kinases regulate the stability of Socs-1 protein","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2005.01.001_bib10","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1128\/jvi.65.11.5880-5885.1991","article-title":"An Epstein\u2013Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator","volume":"65","author":"Cohen","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1101\/gad.1105003","article-title":"The serine\/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor","volume":"17","author":"Fox","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.virol.2005.01.001_bib23","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1128\/MCB.22.7.2136-2146.2002","article-title":"Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins","volume":"22","author":"Han","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.virol.2005.01.001_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(00)80141-0","article-title":"Pim-1 kinase and p100 cooperate to enhance c-Myb activity","volume":"2","author":"Leverson","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.virol.2005.01.001_bib13","first-page":"727","article-title":"Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related","volume":"7","author":"Lilly","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.virol.2005.01.001_bib14","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1038\/sj.onc.1202741","article-title":"The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway","volume":"18","author":"Lilly","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.virol.2005.01.001_bib15","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1182\/blood.V93.6.1980.406k20_1980_1991","article-title":"Interferon-\u03b1 activates multiple STAT proteins and upregulates proliferation-associated IL-2R\u03b1, c-myc, and pim-1 genes in human T cells","volume":"93","author":"Matikainen","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.virol.2005.01.001_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1359-6101(00)00035-6","article-title":"Cytokine signaling and Epstein\u2013Barr virus-mediated cell transformation","volume":"12","author":"Mosialos","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.virol.2005.01.001_bib17","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1182\/blood-2003-09-3126","article-title":"Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3","volume":"103","author":"Peltola","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.virol.2005.01.001_bib18","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.168.4.1524","article-title":"Cutting Edge: transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase","volume":"168","author":"Rainio","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2005.01.001_bib19","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1128\/MCB.15.9.4735","article-title":"The Epstein\u2013Barr virus nuclear protein 2 acidic domain forms complex with a novel cellular coactivator that can interact with TFIIE","volume":"15","author":"Tong","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.virol.2005.01.001_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(89)90589-8","article-title":"Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors","volume":"56","author":"van Lohuizen","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.virol.2005.01.001_bib21","doi-asserted-by":"crossref","first-page":"45358","DOI":"10.1074\/jbc.M307933200","article-title":"The PIM-2 kinase phosphorylates BAD on serine-112 and reverses BAD-induced cell death","volume":"278","author":"Yan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2005.01.001_bib22","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","article-title":"Expression of Epstein\u2013Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease","volume":"321","author":"Young","year":"1989","journal-title":"N. Engl. J. Med."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:32:54Z","timestamp":1758583974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682205000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0042682205000061"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.01.001","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pim kinases are upregulated during Epstein\u2013Barr virus infection and enhance EBNA2 activity","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}